Hexedrone
From Wikipedia, the free encyclopedia
 |
This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages)
(Learn how and when to remove this template message)
|
 |
|
| Names | |
|---|---|
| IUPAC name
2-(Methylamino)-1-phenylhexan-1-one
|
|
| Other names
Hexedrone
|
|
| Identifiers | |
| 3D model (Jmol) | Interactive image |
|
|
| Properties | |
| C13H18NO | |
| Molar mass | 204.29 g·mol−1 |
| Appearance | White crystalline solid |
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
| Infobox references | |
Hexedrone is a stimulant of the substituted cathinone class. Through analysis of the Structure-Activity Relationships in similar cathinones such as MDPV, Hexedrone is believed to be a norepinephrine–dopamine reuptake inhibitor.
Legal status[edit]
In the UK, Hexedrone is a Class B drug under The Misuse of Drugs Act 1971 (Amendment) Order 2010 following the ACMD's report on substituted cathinone derivatives,[1] making it illegal to sell, buy, or possess without a license.[2][3]
See also[edit]
References[edit]
- ^ "ACMD Consideration of The Cathinones" (PDF). ACMD. 31 March 2010.
- ^ "A change to the Misuse of Drugs Act 1971 : Control of mephedrone and other cathinone derivatives". Home Office. 16 April 2010.
- ^ "The Misuse of Drugs Act 1971 (Amendment) Order 2010". Home Office. 12 April 2010.
